Vaginitis and vaginal flora: Controversies abound

Current Opinion in Infectious Diseases

Volumn 9, Issue 1, 1996, Pages 42-47

  Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; FLUCONAZOLE; PYRROLE;

FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LACTOBACILLUS; PATHOGENESIS; PREGNANCY COMPLICATION; REVIEW; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS; VAGINA CANDIDIASIS; VAGINA FLORA; VAGINITIS; VIRUS TRANSMISSION;

EID: 0029868423     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199602000-00011     Document Type: Review

References (35)

1. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goemans J, Behets T, Batter V, Alary M, et al.: Non-ulcerative sexually transmitted diseases as risk factor for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
2. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, Holmes KK: Prevalence of hydrogen peroxide producing lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989, 27:251-256.
3. 2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis 1993, 16(suppl 4):273-281.
4. Horowitz BJ, Giaquinta D, Ito S: Evolving pathogenesis in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992, 32:248-255.
5. Lynch ME, Sobel JD: Comparative in vitro activity of antimycotic agents against pathogenic yeast isolates. J Med Vet Mycol 1994, 32:267-274.
6. Spinillo A, Capuzzo E, Egbe TO, Baltaro F, Nicola S, Piazzi G: Torulopsis glabrata vaginitis. Obstet Gynecol 1995, 85:993-998. A unique review of an extremely large series of 86 consecutive, symptomatic women with isolated Torulopsis glabrata, attending a vaginitis clinic, compared with 625 symptomatic women from whom C. albicans was isolated. The former patients were older, from lower socioeconomic backgrounds, had less education, and were more likely to be HIV-positive. Clinically, patients with T. glabrata vaginitis were less likely to have a white caseous discharge, and vaginitis was more frequently recurrent in nature.
7. Fidel PL Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R: Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 1993, 168:1458-1465.
8. Fong IW: The rectal carriage of yeast in patients with vaginal candidiasis. Clin Invest Med 1994, 17:426-431.
9. Vazquez JA, Sobel JD, Demitriou R, Vaishampayan J, Lynch M, Zervos MJ: Karyotyping of Candida albicans isolates obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994, 170:1566-1569.
10. Schroppel K, Rotman M, Galask R, Mac K, Soll DR: Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J Clin Microbiol 1994, 32:2646-2654.
11. Sobel JD, Brooker D, Stein GE, Thomason JL, Wermeling DP, Bradley B, Weinstein L: Single oral dose fluconasole compared with clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol 1955, 172:1263-1268. A well designed, large prospective study confirming equivalence with conventional topical therapy of single dose fluconazole in the treatment of acute VVC. Substratification analysis, however, revealed that women with severe and recurrent episodes required more prolonged therapy.
12. Jones BM, Eley A, Hicks DA, Patel R, Wordsworth JM: Comparison of the influence of spermicidal and non-spermicidal contraception on bacterial vaginosis, candidal infection and inflammation of the vagina - a preliminary study. Int J STD AIDS 1994, 5:362-364.
13. Hooton TM, Roberts PL, Stamm WF: Effects of recent sexual activity and use of a diaphragm on the vaginal microflora. Clin Infect Dis 1994, 19:274-278. A prospective study of 40 women, evaluating the effects on vaginal microflora of sexual intercourse alone compared with sexual intercourse and use of diaphragm and spermicides. The latter combination was strongly associated with increased vaginal colonization of uropathogenic Eschericia coli, enterococcus, Group B streptococci, and Candida, with decreased rate of lactobacillus colonization. This study emphasized the strong influence of recent use of diaphragm and spermicide on vaginal flora.
14. Spinillo A, Michelone G, Cavanna C, Colonna L, Capuzzo E, Nicola S: Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. Genitourin Med 1994, 70:268-272.
15. Hill GB: Microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993, 169:450-454.
16. MacDermott RIJ: Bacterial vaginosis. Brit J Obstet Gynecol 1995, 102: 92-94.
17. Gardner H, Dukes CD. Hemophilus vaginalis vaginitis: a newly defined specific infection previously classified 'nonspecific' vaginitis. Am J Obstet Gynecol 1955, 69:962-976.
18. Holst E, Goffeng AR, Andesch B: Bacterial vaginosis and vaginal microorganisms in idiopathic premature labor and associated with pregnancy outcome. J Clin Microbiol 1994, 32:176-186.
19. Germain M, Krohn MA, Hillier SL, Eschenbach DA: Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol 1994, 32:2162-2168.
20. Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J: Abnormal bacterial colonization of the lower genital tract as a marker for subsequent preterm delivery and late miscarriage. Br Med J 1994, 308:295-298.
21. Krohn MA, Hillier SL, Nugent RP, Cotch MF, Carey JC, Gibbs RS, Eschenbach DA: The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis 1995, 171:1475-1480. A further publication from the Vaginal Infection and Prematurity Study Group. Among the cohort of 11 989 pregnant women enrolled at 23-26 weeks of duration and followed through delivery, micro-organisms associated with bacterial vaginosis were associated with an increased risk of intra-amniotic infection, as was bacterial vaginosis.
22. Hillier SL, Krohn MA, Cassen E, Easterling TR, Rabe LK, Eschenbach DA: The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis 1995, 20(suppl 2):276-278. This Seattle study of 225 women admitted during preterm labor but with intact fetal membrane confirmed that many of these patients have amniotic fluid infection, and once more documents the association of the latter with bacterial vaginosis. Finally the presence of F. nucleatum and B. ureolyticus in the vagina closely correlates with increased risk of amnionitis, supporting the importance of the ascending route of infection.
23. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R: Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase. Am J Obstet Gynecol 1994, 170:1048-1059. A prospective evaluation of vaginal fluid mucinase and sialidase in 271 pregnant women (16-27 weeks gestation) treated with 2% clindamycin vaginal cream or with placebo. Mucinase and sialidase activities were increased in association with bacterial vaginosis. Topical treatment, although effective treatment of bacterial vaginosis, failed to reduce risks of perinatal morbidity and clinical failure, correlated with persistence of sialidase-producing micro-organisms.
24. Platz-Christensen JJ, Pernevi P, Hagmar B, Anderson F, Brandberg A, Wizvist N: A longitudinal follow-up of bacterial vaginosis during pregnancy. Acta Obstet Gynecol Scand 1993, 72:99-102.
25. Hay PE, Morgan DJ, Ison CA, Bhide SA, Romney M, McKenzie P, Pearson J, Lamont RF, Taylor Robinson D: A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynecol 1994, 101:1048-1053.
26. McDonald HM, O'Laughlin JA, Vigneswaran R, Jolley PT, McDonald PJ: Bacterial vaginosis in pregnancy and efficacy of short courses oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol 1994, 84:343-348.
27. Morales WJ, Schorr S, Albritton J: Effects of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994, 171:345-349. In a prospective study, 80 pregnant women with bacterial vaginosis were randomized to receive metronidazole, 250 mg three times a day for 7 days, or placebo. Compared with placebo, patients in the metronidazole group had significantly less preterm labor, preterm births, and rupture of membranes.
28. McGregor JA, French JI, Parker R, Draper D, Patterson E, Jones W, Thorsgard K, McFee J: Prevention of premature birth by screening and treatment of common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995, 173:157-167. A prospective controlled treatment trial conducted on 1260 women confirmed that the presence of bacterial vaginosis is associated with increased risks of pregnancy loss at < 22 weeks, preterm premature rupture of membranes, and preterm birth. Oral clindamycin treatment was associated with a 50% reduction of bacterial vaginosis-linked preterm birth and premature rupture of membranes.
29. Sweet RL: Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis 1995, 20(suppl 2):271-275.
30. Korn AP, Bolan G, Padian N, Otim-Smith M, Schachter J, Landers DV: Plasma cell endometritis in women with symptomatic bacterial Vaginosis. Obstet Gynecol 1995, 85:387-390. A study of endometrial biopsies obtained from 41 symptomatic women, including 22 with symptomatic bacterial vaginosis, revealed the frequent presence of plasma cell endometritis in women with bacterial vaginosis. This well performed histopathological study strengthens the association between bacterial vaginosis and non-chlamydial, non-gonococcal, upper genital tract infection.
31. Platz-Christensen JJ, Sundstrom E, Larsson PG: bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand 1994, 73:586-588. This is an interesting and potentially extremely important observation linking bacterial vaginosis with the development of cervical intraepithelial neoplasia, possibly a cofactor to human papilloma virus.
32. Sobel JD: Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2% clindamycin therapy. Am J Obstet Gynecol 1994, 171:1215-1220. A retrospective review of 51 women with chronic purulent vaginitis, excluding trichomoniasis, with unique features of epithelial surface desquamation and loss of lactobacillus-dominant flora. Patients frequently failed to respond to oral metronidazole but improved dramatically with clindamycin. Not a controlled study, and microbiological data was incomplete.
33. Horowitz BJ, Mardh PA, Nagy E, Ronk EL: Vaginal lactobacillosis. Am J Obstet Gynecol 1994, 170:857-861.
34. Reid G, Millsap K, Brice AW: Implantation of Lactobacillus casei var rhamnosus into vagina [Letter]. Lancer 1994, 344:1229.
35. Andreu A, Stapleton AE, Fennell CL, Hillier SL, Stamm WE: Hamagglutination, adherence, and surface properties of vaginal lactobacillus species. J Infect Dis 1995, 171:1237-1243.